RCM
SBBP

RA Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

RA Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,279,099
Closed -$5.47M – 30
2016
Q4 		$5.47M Sell
2,279,099
-222,568
-9% -$907K 0.78% 18
2016
Q3 		$13.1M Sell
2,501,667
-173,671
-6% -$783K 1.35% 18
2016
Q2 		$10.6M Sell
2,675,338
-15,364
-0.6% -$72.5K 1.47% 16
2016
Q1 		$12.3M Hold
2,690,702
– – 1.57% 21
2015
Q4 		$20.4M Buy
+2,690,702
New +$19.3M 2.02% 16

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RA Capital Management's SBBP Position: Q1 2017 in Review

RA Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2017, closing a stake of 2,279,099 shares — an estimated $5.47M sold.

RA Capital Management first reported a position in SBBP in Q4 2015 and held it in 5 quarters. The position peaked at $20.4M in Q4 2015. 19 funds tracked by Wall St. Rank hold SBBP as of Q1 2017.

  • RA Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2017 after selling out during the quarter.
  • RA Capital Management sold 2,279,099 Strongbridge Biopharma plc. shares in Q1 2017, an estimated $5.47M.
  • RA Capital Management first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 5 quarters.
  • RA Capital Management's Strongbridge Biopharma plc. position peaked at $20.4M in Q4 2015.
  • 19 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2017.

Based on RA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.